Intra-Cellular Therapies Inc. (ITCI) by event type
ITCI moves most on price-target raises — a median of -0.44% at 30 minutes across 21 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ITCI overview →
How ITCI reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 1,544 of 2,603 | 20 | -0.04% | 25% | -0.15% |
| Coverage initiations 1,386 of 2,283 | 15 | -0.03% | 13% | -0.09% |
| Rating reiterations 1,557 of 3,522 | 65 | +0.00% | 51% | -0.08% |
| Price-target raises 1,708 of 1,790 | 21 | -0.44% | 24% | -0.72% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how ITCI usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · ITCI overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MELINTA THERAPEUTICS INC (MLNT) | 248 | -0.38% | 34% |
| Heron Therapeutics, Inc. (HRTX) | 247 | -0.34% | 42% |
| Avadel Pharmaceuticals plc - Ordinary Share (AVDL) | 246 | -0.16% | 42% |
| Cumberland Pharmaceuticals Inc. (CPIX) | 245 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.